These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9485534)

  • 1. Nefazodone and REM sleep: how do antidepressant drugs decrease REM sleep?
    Vogal G; Cohen J; Mullis D; Kensler T; Kaplita S
    Sleep; 1998; 21(1):70-7. PubMed ID: 9485534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of paroxetine and nefazodone on sleep: a placebo controlled trial.
    Sharpley AL; Williamson DJ; Attenburrow ME; Pearson G; Sargent P; Cowen PJ
    Psychopharmacology (Berl); 1996 Jul; 126(1):50-4. PubMed ID: 8853216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: a double-blind, 8-week clinical trial.
    Gillin JC; Rapaport M; Erman MK; Winokur A; Albala BJ
    J Clin Psychiatry; 1997 May; 58(5):185-92. PubMed ID: 9184611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicenter, double-blind comparison of the effects of nefazodone and fluoxetine on sleep architecture and quality of sleep in depressed outpatients.
    Armitage R; Yonkers K; Cole D; Rush AJ
    J Clin Psychopharmacol; 1997 Jun; 17(3):161-8. PubMed ID: 9169959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder.
    Rush AJ; Armitage R; Gillin JC; Yonkers KA; Winokur A; Moldofsky H; Vogel GW; Kaplita SB; Fleming JB; Montplaisir J; Erman MK; Albala BJ; McQuade RD
    Biol Psychiatry; 1998 Jul; 44(1):3-14. PubMed ID: 9646878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. REM sleep and nefazodone.
    Ware JC; McBrayer RH
    Sleep; 1998 Dec; 21(8):795-6. PubMed ID: 9871941
    [No Abstract]   [Full Text] [Related]  

  • 7. Nefazodone treatment and dream reports in chronic PTSD.
    Mellman TA; David D; Barza L
    Depress Anxiety; 1999; 9(3):146-8. PubMed ID: 10356655
    [No Abstract]   [Full Text] [Related]  

  • 8. The acute effects of nefazodone, trazodone and buspirone on sleep and sleep-related penile tumescence in normal subjects.
    Ware JC; Rose FV; McBrayer RH
    Sleep; 1994 Sep; 17(6):544-50. PubMed ID: 7809568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nefazodone--a novel antidepressant--may increase REM sleep.
    Sharpley AL; Walsh AE; Cowen PJ
    Biol Psychiatry; 1992 May; 31(10):1070-3. PubMed ID: 1511078
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of nefazodone on women with seasonal affective disorder: clinical and polysomnographic analyses.
    Shen J; Kennedy SH; Levitan RD; Kayumov L; Shapiro CM
    J Psychiatry Neurosci; 2005 Jan; 30(1):11-6. PubMed ID: 15644992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved sleep continuity and increased slow wave sleep and REM latency during ziprasidone treatment: a randomized, controlled, crossover trial of 12 healthy male subjects.
    Cohrs S; Meier A; Neumann AC; Jordan W; Rüther E; Rodenbeck A
    J Clin Psychiatry; 2005 Aug; 66(8):989-96. PubMed ID: 16086613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomised controlled study of sleep after nefazodone or paroxetine treatment in out-patients with depression.
    Hicks JA; Argyropoulos SV; Rich AS; Nash JR; Bell CJ; Edwards C; Nutt DJ; Wilson SJ
    Br J Psychiatry; 2002 Jun; 180():528-35. PubMed ID: 12042232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sleep laboratory study on single and repeated dose effects of paroxetine, alprazolam and their combination in healthy young volunteers.
    Barbanoj MJ; Clos S; Romero S; Morte A; Giménez S; Lorenzo JL; Luque A; Dal-Ré R
    Neuropsychobiology; 2005; 51(3):134-47. PubMed ID: 15838185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redistribution of slow wave activity of sleep during pharmacological treatment of depression with paroxetine but not with nefazodone.
    Argyropoulos SV; Hicks JA; Nash JR; Bell CJ; Rich AS; Nutt DJ; Wilson S
    J Sleep Res; 2009 Sep; 18(3):342-8. PubMed ID: 19549078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of nefazodone on sleep architecture in depression.
    Armitage R; Rush AJ; Trivedi M; Cain J; Roffwarg HP
    Neuropsychopharmacology; 1994 Apr; 10(2):123-7. PubMed ID: 8024673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translational evaluation of JNJ-18038683, a 5-hydroxytryptamine type 7 receptor antagonist, on rapid eye movement sleep and in major depressive disorder.
    Bonaventure P; Dugovic C; Kramer M; De Boer P; Singh J; Wilson S; Bertelsen K; Di J; Shelton J; Aluisio L; Dvorak L; Fraser I; Lord B; Nepomuceno D; Ahnaou A; Drinkenburg W; Chai W; Dvorak C; Sands S; Carruthers N; Lovenberg TW
    J Pharmacol Exp Ther; 2012 Aug; 342(2):429-40. PubMed ID: 22570363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiated effects of the multimodal antidepressant vortioxetine on sleep architecture: Part 1, a pharmacokinetic/pharmacodynamic comparison with paroxetine in healthy men.
    Wilson S; Højer AM; Buchberg J; Areberg J; Nutt DJ
    J Psychopharmacol; 2015 Oct; 29(10):1085-91. PubMed ID: 26253622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pharmacologic treatments on the sleep of depressed patients.
    Sharpley AL; Cowen PJ
    Biol Psychiatry; 1995 Jan; 37(2):85-98. PubMed ID: 7718684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute and subchronic effects of nefazodone and imipramine on highway driving, cognitive functions, and daytime sleepiness in healthy adult and elderly subjects.
    van Laar MW; van Willigenburg AP; Volkerts ER
    J Clin Psychopharmacol; 1995 Feb; 15(1):30-40. PubMed ID: 7714226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiated effects of the multimodal antidepressant vortioxetine on sleep architecture: Part 2, pharmacological interactions in rodents suggest a role of serotonin-3 receptor antagonism.
    Leiser SC; Iglesias-Bregna D; Westrich L; Pehrson AL; Sanchez C
    J Psychopharmacol; 2015 Oct; 29(10):1092-105. PubMed ID: 26174134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.